These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 24655477)
1. Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium. Aust S; Auer K; Bachmayr-Heyda A; Denkert C; Sehouli J; Braicu I; Mahner S; Lambrechts S; Vergote I; Grimm C; Horvat R; Castillo-Tong DC; Zeillinger R; Pils D Mol Cancer; 2014 Mar; 13():67. PubMed ID: 24655477 [TBL] [Abstract][Full Text] [Related]
2. Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer. Stone RL; Baggerly KA; Armaiz-Pena GN; Kang Y; Sanguino AM; Thanapprapasr D; Dalton HJ; Bottsford-Miller J; Zand B; Akbani R; Diao L; Nick AM; DeGeest K; Lopez-Berestein G; Coleman RL; Lutgendorf S; Sood AK Cancer Biol Ther; 2014 Jul; 15(7):919-29. PubMed ID: 24755674 [TBL] [Abstract][Full Text] [Related]
3. Pilot study: alteration of deleted in liver cancer1 and phosphorylated focal adhesion kinase Y397 cytoplasmic expression and the prognostic value in advanced epithelial ovarian carcinoma. Fan DM; Shi HR Int J Mol Sci; 2011; 12(12):8489-501. PubMed ID: 22272086 [TBL] [Abstract][Full Text] [Related]
4. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma. Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700 [TBL] [Abstract][Full Text] [Related]
5. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
6. Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium. Pils D; Hager G; Tong D; Aust S; Heinze G; Kohl M; Schuster E; Wolf A; Sehouli J; Braicu I; Vergote I; Cadron I; Mahner S; Hofstetter G; Speiser P; Zeillinger R Cancer Sci; 2012 Jul; 103(7):1334-41. PubMed ID: 22497737 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer. Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963 [TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression. Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591 [TBL] [Abstract][Full Text] [Related]
9. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations. Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CPS1-IT1 is a positive prognostic factor and inhibits epithelial ovarian cancer tumorigenesis. Wang YS; Ma LN; Sun JX; Liu N; Wang H Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3169-3175. PubMed ID: 28770969 [TBL] [Abstract][Full Text] [Related]
11. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC). Shuang T; Wang M; Zhou Y; Shi C Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143 [TBL] [Abstract][Full Text] [Related]
12. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer. Guo B; Yan H; Li L; Yin K; Ji F; Zhang S J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002 [TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase overexpression and its impact on human osteosarcoma. Ren K; Lu X; Yao N; Chen Y; Yang A; Chen H; Zhang J; Wu S; Shi X; Wang C; Sun X Oncotarget; 2015 Oct; 6(31):31085-103. PubMed ID: 26393679 [TBL] [Abstract][Full Text] [Related]
14. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer. Ma M; Yu N Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213 [TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer. Berntsson J; Lundgren S; Nodin B; Uhlén M; Gaber A; Jirström K J Ovarian Res; 2014 Feb; 7():26. PubMed ID: 24568264 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Peng DX; Luo M; Qiu LW; He YL; Wang XF Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341 [TBL] [Abstract][Full Text] [Related]
17. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer. Hou S; Du P; Wang P; Wang C; Liu P; Liu H Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. Cho H; Lee YS; Kim J; Chung JY; Kim JH Cancer Invest; 2013 Nov; 31(9):607-15. PubMed ID: 24164300 [TBL] [Abstract][Full Text] [Related]
19. Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells. Zhu L; Hu Z; Liu J; Gao J; Lin B Med Oncol; 2015 Jan; 32(1):426. PubMed ID: 25502083 [TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin expression in epithelial ovarian cancers and promotes HO8910 cell migration associated with upregulating integrin α5β1 and phosphorylating FAK and paxillin. Deng B; Zhang S; Miao Y; Han Z; Zhang X; Wen F; Zhang Y J Exp Clin Cancer Res; 2012 Mar; 31(1):19. PubMed ID: 22400488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]